港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

银诺医药－Ｂ

44.000

+2.6606.43%

成交量：119.30万

成交额：5,255.83万

市值：201.00亿

市盈率：-95.97

高：44.920

开：41.360

低：41.360

收：41.340

52周最高：74.000

52周最低：28.400

股本：4.57亿

香港流通股本：4.20亿

量比：2.49

换手率：0.28%

股息：- -

股息率：- -

每股收益(LYR):-0.458

净资产收益率：-23.27%

总资产收益率：-11.61%

市净率：26.73

市盈率(LYR):-95.97

市销率: 323.32

数据加载中...

总览公司新闻资讯公告

港股异动 | 银诺医药-B(02591)再涨超5% 下周一正式进入恒生综指机构称其符合港股通纳入范围

银诺医药-B12月04日获主力加仓73.2万元

广州银诺医药（2591）11月股份变动月报：股本保持稳定

银诺医药-B12月03日获主力加仓67.3万元

银诺医药－Ｂ(02591)股价下跌5.051%，现价港币$37.6

阿斯达克财经

银诺医药-B(02591)及银诺技术合共认购1.25亿元宁波银行结构性存款产品

银诺医药－Ｂ：12月1日认购结构性存款产品，金额达1.25亿元人民币

银诺医药-B盘中异动股价大跌5.51%

上市首日大涨近90%！港股主板打新超购创纪录，热门赛道小市值股受追捧！

一周港股牛熊榜 | 恒生综合指数新贵银诺医药、禾赛分别飙51%、25%；机器人概念热炒、广汽集团一周升31%；深陷债务泥潭、万科企业跌13%

老虎资讯综合

银诺医药-B11月28日获主力加仓181.2万元

港股异动 | 银诺医药-B(02591)再涨近7% 四个交易日股价累涨超50% 将被纳入恒生综合指数

港股异动 | 银诺医药-B(02591)再涨超6% 昨日股价飙涨超30% 公司获纳入恒生综指

银诺医药-B11月24日主力净流入448.4万元散户资金抛售

港股异动 | 银诺医药-B(02591)涨近10% 获纳入恒生综合指数 12月8日起生效

智通港股52周新高、新低统计|11月21日

银诺医药-B盘中异动急速跳水5.20%

银诺医药-B股价大跌5.42% 依苏帕格鲁肽αIII期临床试验完成首例给药

银诺医药-B11月17日获主力加仓221.1万元

药企赴港IPO火爆，半个月8家递表，基石投资者“快看不过来了”

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02591/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"银诺医药－Ｂ","latestPrice":44,"timestamp":1764922146460,"preClose":41.34,"halted":0,"volume":1193000,"delay":0,"floatShares":420285370,"shares":456819349,"eps":-0.4584694829822348,"marketStatus":"休市中","change":2.66,"latestTime":"12-05 16:09:06","open":41.36,"high":44.92,"low":41.36,"amount":52558318,"amplitude":0.086115,"askPrice":44.76,"askSize":1600,"bidPrice":44,"bidSize":25600,"shortable":0,"etf":0,"ttmEps":-0.5814706163529356,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":41.34,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":2.4920621652027766,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-11.61%","roe":"-23.27%","lyrEps":-0.458469,"volumeRatio":2.4920621652027766,"shares":456819349,"dividePrice":0,"high":44.92,"amplitude":0.086115,"preClose":41.34,"low":41.36,"week52Low":28.4,"pbRate":"26.73","psRate":"323.32","week52High":74,"institutionHeld":0,"latestPrice":44,"committee":0.882353,"eps":-0.4584694829822348,"divideRate":0,"volume":1193000,"delay":0,"ttmEps":-0.5814706163529356,"open":41.36,"prevYearClose":18.68,"prevWeekClose":43.94,"prevMonthClose":43.94,"prevQuarterClose":39.32,"fiveDayClose":43.94,"twentyDayClose":30,"sixtyDayClose":46.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2025-12-05","current":-75.670204,"percent":0.272727,"low":-137.156472,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"high":-54.467459,"avg":-78.788716,"sd":20.619693,"marketCap":20100051356},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356}],"updateTime":1765105533617},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589854273","title":"港股异动 | 银诺医药-B(02591)再涨超5% 下周一正式进入恒生综指 机构称其符合港股通纳入范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2589854273","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589854273?lang=zh_cn&edition=fundamental","pubTime":"2025-12-05 10:05","pubTimestamp":1764900344,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)再涨超5%，股价暂现三连阳。截至发稿，涨5.03%，报43.42港元，成交额764.33万港元。消息面上，恒生指数系列季度检讨结果此前公布，其中，银诺医药获纳入恒生综合指数成份股，变动将于2025年12月8日起生效。据中金预测，银诺医药等符合港股通纳入范围。公开资料显示，银诺医药是一家专注于代谢性疾病领域的生物医药公司，目前拥有多项针对糖尿病、肥胖和非酒精性脂肪性肝炎等适应症的创新药物研发管线，全部为自主研发，具备全球知识产权，覆盖全球研发与市场布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2588882596","title":"银诺医药-B12月04日获主力加仓73.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588882596","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588882596?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 16:16","pubTimestamp":1764836164,"startTime":"0","endTime":"0","summary":"12月04日, 银诺医药-B股价涨5.41%，报收41.34元，成交金额1978.7万元，换手率0.12%，振幅6.17%，量比0.76。银诺医药-B今日主力资金净流入73.2万元，连续3日净流入，上一交易日主力净流入67.3万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为100.00%，平均涨幅为3.45%。该股近5个交易日下跌5.57%，主力资金累计净流入309.0万元；近20日主力资金累计净流入3187.8万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162247a723519b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204162247a723519b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":1},{"id":"1153185179","title":"广州银诺医药（2591）11月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1153185179","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153185179?lang=zh_cn&edition=fundamental","pubTime":"2025-12-03 17:03","pubTimestamp":1764752618,"startTime":"0","endTime":"0","summary":"广州银诺医药集团股份有限公司于2025年12月3日发布2025年11月股份变动月报。公告显示，截至2025年11月30日，公司注册股本为人民币456,819,349元，包括420,285,370股在香港联交所上市的H股及36,533,979股非上市股份，面值均为每股人民币1元；本月内上述股数无增减变动。根据公告所载信息，本次月报由公司联席公司秘书金今签署，公司确认已遵守香港联交所上市规则及相关法律法规。综上所述，截至2025年11月末，公司股本保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2588028481","title":"银诺医药-B12月03日获主力加仓67.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588028481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588028481?lang=zh_cn&edition=fundamental","pubTime":"2025-12-03 16:15","pubTimestamp":1764749756,"startTime":"0","endTime":"0","summary":"12月03日, 银诺医药-B股价涨3.65%，报收39.22元，成交金额1432.3万元，换手率0.09%，振幅5.44%，量比0.51。银诺医药-B今日主力资金净流入67.3万元，上一交易日主力净流入33.5万元。该股近5个交易日下跌6.74%，主力资金累计净流入822.9万元；近20日主力资金累计净流入3370.9万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162123978d74d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203162123978d74d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2588080774","title":"银诺医药－Ｂ(02591)股价下跌5.051%，现价港币$37.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2588080774","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588080774?lang=zh_cn&edition=fundamental","pubTime":"2025-12-02 15:29","pubTimestamp":1764660540,"startTime":"0","endTime":"0","summary":"[下跌股]银诺医药－Ｂ(02591) 股价在下午03:29比前收市价下跌5.051%，现股价为港币$37.6。至目前为止，今日最高价为$41.1，而最低价为$37.6。总成交量为36.5万股，总成交金额为港币$1.445千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2512021700/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2588275897","title":"银诺医药-B(02591)及银诺技术合共认购1.25亿元宁波银行结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2588275897","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588275897?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 20:34","pubTimestamp":1764592470,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B(02591)公布，于2025年12月1日，公司及银诺技术(公司一间直接全资附属公司)以代价合共人民币1.25亿元(即其总本金额)分别向宁波银行认购一款结构性存款产品(即宁波银行结构性存款产品)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2580892862.HKD","002142","BK0028","LU1820825898.SGD","LU1146622755.USD","LU2097828805.USD","LU1655091616.SGD","SGXZ49509284.SGD","BK0187","SGXZ81163826.USD","LU2097828631.EUR","LU1969619763.USD","LU1794554557.SGD","LU0140636845.USD","BK0201","BK0183","02591","BK0188","LU1720050803.USD","LU2097828714.EUR","LU2328871848.SGD","LU2097828474.EUR","BK0278","BK0197","LU2097828557.USD","LU1688375341.USD","LU2580892789.USD"],"gpt_icon":0},{"id":"1157495277","title":"银诺医药－Ｂ：12月1日认购结构性存款产品，金额达1.25亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1157495277","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157495277?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 20:34","pubTimestamp":1764592449,"startTime":"0","endTime":"0","summary":"银诺医药－Ｂ于12月1日认购了金额为1.25亿元人民币的结构性存款产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2588747160","title":"银诺医药-B盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588747160?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 09:38","pubTimestamp":1764553082,"startTime":"0","endTime":"0","summary":"2025年12月01日早盘09时38分，银诺医药-B股票出现波动，股价大幅跳水5.51%。银诺医药-B股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，华昊中天医药-B、维升药业-B、来凯医药-B涨幅较大，振幅较大的相关个股有银诺医药-B、中基长寿科学、拨康视云-B，振幅分别为6.83%、5.17%、4.47%。银诺医药-B公司简介：广州银诺医药集团股份有限公司是一家主要从事医药产品的研发及商业化的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201093802a71baabb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201093802a71baabb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2587750263","title":"上市首日大涨近90%！港股主板打新超购创纪录，热门赛道小市值股受追捧！","url":"https://stock-news.laohu8.com/highlight/detail?id=2587750263","media":"e公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587750263?lang=zh_cn&edition=fundamental","pubTime":"2025-11-29 17:49","pubTimestamp":1764409777,"startTime":"0","endTime":"0","summary":"2025年，港股打新热潮席卷市场。继创业板新股金叶国际集团创下1.15万倍港股史上最高超购纪录后，主板新股量化派以9365.28倍的超购倍数刷新主板历史纪录。事实上，今年的港股新股市场诞生了一系列超购纪录。若计入创业板新股金叶国际集团，则位列港股史上第二。超购纪录不断被刷新2025年港股新股申购火爆，超购纪录不断被刷新，与往年形成鲜明对比。中信证券表示，政策催化、交投火热、外资回流催生了港股打新市场热度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251129175840a4c20a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251129175840a4c20a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01716","BK1117","BK1137","01384","02591","02097","02685","00325","02630"],"gpt_icon":1},{"id":"1177974852","title":"一周港股牛熊榜 | 恒生综合指数新贵银诺医药、禾赛分别飙51%、25%；机器人概念热炒、广汽集团一周升31%；深陷债务泥潭、万科企业跌13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177974852","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177974852?lang=zh_cn&edition=fundamental","pubTime":"2025-11-28 19:00","pubTimestamp":1764327644,"startTime":"0","endTime":"0","summary":"消息面上，11月21日，恒生指数公司发布季度检讨结果，相关变动将于2025年12月5日收市后实施，并于2025年12月8日起生效。第三季度，公司经调整利润达2410.8万美元，同比增长126.0%，环比增长51.0%。11月27日，万科A股大跌超过7%。11月12日，万科公告称，深铁集团向其提供了不超过16.66亿元借款。目前，万科亏损较大。2025年前三季度，万科实现营业收入1613.9亿元，同比下降26.61%；净利润亏损280.2亿元。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"634cd6212949dd3f0bfe745f2cf2a7d9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周港股牛熊榜 | 恒生综合指数新贵银诺医药、禾赛分别飙51%、25%；机器人概念热炒、广汽集团一周升31%...","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01729","02525","02570","01384","02202","02238","01735","02591","01860","00108"],"gpt_icon":1},{"id":"2587975270","title":"银诺医药-B11月28日获主力加仓181.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2587975270","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587975270?lang=zh_cn&edition=fundamental","pubTime":"2025-11-28 16:15","pubTimestamp":1764317749,"startTime":"0","endTime":"0","summary":"11月28日, 银诺医药-B股价涨0.37%，报收43.94元，成交金额2013.5万元，换手率0.11%，振幅9.18%，量比0.53。银诺医药-B今日主力资金净流入181.2万元，连续3日净流入，上一交易日主力净流入587.2万元。该股近5个交易日上涨51.80%，主力资金累计净流入1668.3万元；近20日主力资金累计净流入3488.6万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112816231297845f03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112816231297845f03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2586413213","title":"港股异动 | 银诺医药-B(02591)再涨近7% 四个交易日股价累涨超50% 将被纳入恒生综合指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2586413213","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586413213?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 11:52","pubTimestamp":1764215566,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)再涨近7%，四个交易日股价累计涨超50%。截至发稿，涨6.79%，报44.68港元，成交额3536.66万港元。消息面上，11月21日，恒生指数系列季度检讨结果出炉，其中，银诺医药获纳入恒生综合指数成份股，变动将于2025年12月8日起生效。据中金预测，银诺医药等符合港股通纳入范围。据悉，银诺医药是一家专注于代谢性疾病领域的生物医药公司，目前拥有多项针对糖尿病、肥胖和非酒精性脂肪性肝炎等适应症的创新药物研发管线，全部为自主研发，具备全球知识产权，覆盖全球研发与市场布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCI","02591","BK1161"],"gpt_icon":0},{"id":"2586438624","title":"港股异动 | 银诺医药-B(02591)再涨超6% 昨日股价飙涨超30% 公司获纳入恒生综指","url":"https://stock-news.laohu8.com/highlight/detail?id=2586438624","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586438624?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 11:28","pubTimestamp":1764041311,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B(02591)再涨超6%，昨日股价飙涨超30%。截至发稿，涨6.11%，报40.3港元，成交额2313.13万港元。消息面上，11月21日，恒生指数系列季度检讨结果出炉，所有变动将于2025年12月8日起生效。其中，银诺医药获纳入恒生综合指数成份股。上海证券此前研报指出，银诺医药依苏帕格鲁肽α具有良好的安全性和降糖、减重效果，在治疗糖尿病、肥胖、脂肪肝等慢性代谢性疾病方面表现显著优势，公司登陆港交所有望推进研发管线及商业化拓展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"港股异动 | 银诺医药-B(02591)再涨超6% 昨日股价飙涨超30% 公司获纳入恒生综指","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2586141638","title":"银诺医药-B11月24日主力净流入448.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586141638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586141638?lang=zh_cn&edition=fundamental","pubTime":"2025-11-24 16:15","pubTimestamp":1763972135,"startTime":"0","endTime":"0","summary":"11月24日, 银诺医药-B股价涨31.15%，报收37.98元，成交金额4156.0万元，换手率0.28%，振幅32.80%，量比2.78。银诺医药-B今日主力资金净流入448.4万元，上一交易日主力净流出30.5万元。该股近5个交易日上涨10.15%，主力资金累计净流入814.4万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流入2267.8万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124161842a4b69b65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124161842a4b69b65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2585843451","title":"港股异动 | 银诺医药-B(02591)涨近10% 获纳入恒生综合指数 12月8日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2585843451","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585843451?lang=zh_cn&edition=fundamental","pubTime":"2025-11-24 10:12","pubTimestamp":1763950333,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，银诺医药-B涨近10%，截至发稿，涨9.81%，报31.8港元，成交额276.93万港元。消息面上，11月21日，恒生指数系列季度检讨结果出炉，所有变动将于2025年12月8日起生效。其中，银诺医药获纳入恒生综合指数成份股。今年9月，银诺医药发布公告称，公司已在中国完成核心产品用于治疗肥胖和超重的III期临床试验的首例患者给药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","HSCI","02591"],"gpt_icon":0},{"id":"2585113602","title":"智通港股52周新高、新低统计|11月21日","url":"https://stock-news.laohu8.com/highlight/detail?id=2585113602","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585113602?lang=zh_cn&edition=fundamental","pubTime":"2025-11-21 16:40","pubTimestamp":1763714401,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月21日收盘，有14只股票创52周新高，其中恒发光学、朝威控股、木薯资源创高率位于前3位，分别为42.11%、30.56%、22.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01029","08500","00180","00599","02587","01121","01653","02591","02818","00341","09688","02453","09878","00610","00500","00841","01855","00699","03880","01274","01304","06960","00848","01134","00182","02508","02535","02543","06687","00040","01004","02515","00917","06603","02367","00325","00314","01745","01865","00397","01498","01773","02431","01830","01119","01268","02246","00638","02011"],"gpt_icon":1},{"id":"2585013141","title":"银诺医药-B盘中异动 急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585013141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585013141?lang=zh_cn&edition=fundamental","pubTime":"2025-11-21 09:39","pubTimestamp":1763689157,"startTime":"0","endTime":"0","summary":"2025年11月21日早盘09时39分，银诺医药-B股票出现波动，股价大幅跳水5.20%。截至发稿，该股报29.920港元/股，成交量9600股，换手率0.00%，振幅4.69%。银诺医药-B股票所在的生物技术行业中，整体跌幅为1.87%。银诺医药-B公司简介：广州银诺医药集团股份有限公司是一家主要从事医药产品的研发及商业化的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112109391795119aba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112109391795119aba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2584994008","title":"银诺医药-B股价大跌5.42% 依苏帕格鲁肽αIII期临床试验完成首例给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2584994008","media":"港美通","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584994008?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 10:32","pubTimestamp":1763519571,"startTime":"0","endTime":"0","summary":"11月19日10:23，银诺医药-B(02591)股价大幅下跌5.42%。该股报32.120港元，最高报33.960港元，最低报32.120港元，成交量10.74万股，成交额353.47万港元。消息面上，银诺医药-B近日发布公告称，公司核心产品依苏帕格鲁肽α用于治疗肥胖和超重的III期临床试验已完成首例患者给药。广州银诺医药集团股份有限公司是一家科学驱动的生物制药公司,致力于为代谢性疾病患者提供创新的,可及且可负担的高质量药品。公司目前已拥有多项针对糖尿病、肥胖,代谢功能障碍相关适应症的研发管线,且所有管线均为自主研发,拥有全球专利,并布局全球研发和市场销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119104017950d742c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119104017950d742c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2584449679","title":"银诺医药-B11月17日获主力加仓221.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584449679","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584449679?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:15","pubTimestamp":1763367315,"startTime":"0","endTime":"0","summary":"11月17日, 银诺医药-B股价涨4.61%，报收34.48元，成交金额1475.3万元，换手率0.10%，振幅4.73%，量比1.00。银诺医药-B今日主力资金净流入221.1万元，连续5日净流入，上一交易日主力净流入26.6万元。该股近5个交易日上涨6.25%，主力资金累计净流入1119.3万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1453.3万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117161557a4a72124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117161557a4a72124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2583363717","title":"药企赴港IPO火爆，半个月8家递表，基石投资者“快看不过来了”","url":"https://stock-news.laohu8.com/highlight/detail?id=2583363717","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583363717?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 16:43","pubTimestamp":1763196217,"startTime":"0","endTime":"0","summary":"“我们正在中国香港进行IPO路演，但这段时间药企扎堆申报港股IPO，已形成了‘堰塞湖’，基石投资者和锚定投资者都快看不过来了，我们遭遇路演排队。”有赴港IPO药企人士对第一财经记者透露。今年以来，港股医药二级市场的复苏，提振了企业们IPO融资热情。根据Choice金融终端数据，截至11月14日，港股的医疗保健板块今年累计迎来了23家企业成功上市，而去年同期仅有8家企业上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://hk.eastmoney.com/news/11792,202511153565388760.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/news/11792,202511153565388760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["LU2580892862.HKD","GIC","LU1328615791.USD","IE00B29SXG58.USD","LU0572944931.SGD","300760","HK0000252152.HKD","02615","HK0000252160.HKD","09606","688506","LU0605514214.HKD","LU1934453819.USD","LU2097828714.EUR","LU2153592121.USD","LU2213484517.USD","LU1023057109.AUD","600276","LU1720050803.USD","LU1146622755.USD","LU2153591404.USD","LU0359201612.USD","LU1979443071.USD","LU2148510915.USD","LU1734074674.USD","LU1997244956.HKD","HK0000500386.USD","LU1655091616.SGD","LU1064130708.USD","SGXZ81163826.USD","LU2097828474.EUR","LU0823426308.USD","LU1688375341.USD","LU2097828805.USD","IE0031814852.USD","LU0405327494.USD","LU1580142542.USD","LU1064131003.USD","LU0594300179.USD","BK4104","09939","02595","09887","02591","LU1781817850.SGD","SGXZ49509284.SGD","02617","BK0196","300558","BK1515"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":120,"code":"91000000","status":"200"}]}}